Brilinta Oral Tablet 90Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

BRILINTA: Oral tablet (90mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14763.JPG
BRILINTA 90mg Tablet
AstraZeneca LP
Pill Identification: 90 T 

What is this Medicine?

TICAGRELOR (TYE ka GREL or) helps to prevent blood clots. This medicine is used to prevent heart attack, stroke, or other vascular events in people who have had a recent heart attack or who have severe chest pain.

CVS Pharmacy Patient Statistics for BRILINTA: Oral tablet(90mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

BRILINTA 90mg Tablet

NDC: 001860777
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Myocardial Infarction, Percutaneous Coronary Intervention (PCI), Arterial Thromboembolism Prophylaxis, Unstable Angina

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
BRILINTA 90mg Tablet
Drug Image file DrugItem_14763.JPG
AstraZeneca LP
Pill Identification: 90 T 
Shape: round
Color: yellow

Reported Side Effects for BRILINTA 90mg Tablet

Gynecomastia Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Bleeding In The Brain Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
High Uric Acid Level Incidence:
0.6%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
1.7%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
2.2-6.6%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
3.1%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
3.2%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
3.2%*
Severity: MODERATE
Onset: RAPID
Back Pain Incidence:
3.6%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
3.7%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
3.8%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
4.3%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.5%*
Severity: MILD
Onset: EARLY
Irregular Heart Beat Incidence:
4.6%*
Severity: SEVERE
Onset: EARLY
Cough Incidence:
4.9%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
6.5%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
8.7%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
13.8%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for BRILINTA 90mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and BRILINTA 90mg Tablet(Ticagrelor)
Grapefruit juice and Ticagrelor(Ticagrelor)
Side effects from ticagrelor may get worse if you drink grapefruit juice. Drinking grapefruit juice while taking this medicine may increase your risk of bleeding. Immediately report any unusual bleeding or bruising.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with BRILINTA

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.